• CXCR4 Theranostics in Lymphoma: Evidence Review

  2026-10-05

  Dhamecha and colleagues review how CXCR4-targeted imaging and therapeutic agents could connect lymphoma characterization with precision treatment selection. The paper’s main contribution is a theranostic framework that integrates receptor biology, PET or SPECT ligand development, targeted therapy, and translational limitations rather than reporting a new intervention trial.

• EZ Cap™ Human PTEN mRNA (ψUTP): Evidence to Insight

  2026-10-05

  Explore how EZ Cap™ Human PTEN mRNA (ψUTP) can serve as a mechanistic research tool for studying PTEN restoration, PI3K/Akt signaling, and therapy resistance. This evidence-centered guide separates product design rationale from findings demonstrated in nanoparticle-based cancer models.

• A-Eudesmol and Cav2.1 Channels in Brain Ischemia

  2026-10-04

  Asakura and colleagues linked inhibition of ω-agatoxin IVA-sensitive calcium channels with reduced glutamate release and protection from edema and infarction after focal cerebral ischemia in rats. The study is important because it connects presynaptic calcium-channel pharmacology with an in vivo neuroprotection phenotype, while also showing why selectivity and model-specific evidence must be interpreted cautiously.

• BCA Protein Quantification Kit K4102 Overview

  2026-10-03

  A concise, supplier-documented overview of APExBIO’s BCA Protein Quantification Kit K4102, including its stated assay principle, measurement scope, and evidence limitations.

• Mavorixafor in WHIM Syndrome: Phase 3 Evidence

  2026-10-02

  A placebo-controlled phase 3 trial shows that oral CXCR4 antagonism with mavorixafor can extend neutrophil and lymphocyte availability and reduce infections in patients with WHIM syndrome. The findings support a disease-directed strategy for this rare immunodeficiency while leaving important questions about long-term safety, antibody responses, malignancy risk, and treatment durability unresolved.

• BKT140 (BL-8040) CXCR4 Research Workflows

  2026-10-01

  Build practical CXCR4 studies around BKT140 (BL-8040), from migration and apoptosis assays to tumor-microenvironment and stem-cell mobilization models. This workflow-focused guide emphasizes formulation, controls, quantitative readouts, and troubleshooting for reproducible oncology research.

• Serum-Free Cell Freezing Medium for LNP Assays

  2026-10-01

  Discover how Serum-Free Cell Freezing Medium can strengthen the reproducibility of cell-based mRNA–LNP assays by controlling pre-analytical variability. This article connects cryopreservation strategy with CMC principles, potency testing, and translational comparability.

• Structural Basis of P/Q-Type Cav2.1 Toxin Sensitivity

  2026-09-30

  The 2024 Cell Research study used electrophysiology and cryo-electron microscopy to explain why P-type and Q-type Cav2.1 channels differ in sensitivity to ω-agatoxin IVA. Its structures distinguish toxin binding at the voltage-sensing domain from pore occlusion, providing a mechanistic framework for selective Cav2.1 pharmacology and improved interpretation of neuronal calcium-channel experiments.

• Autophagy–Liver Metastasis Signature in Colorectal Cancer

  2026-09-30

  Bai et al. integrated bulk and single-cell transcriptomic analyses to develop a six-gene prognostic signature linking autophagy, liver metastasis, immune dysfunction, and treatment-related phenotypes in colorectal cancer. The study provides a framework for risk stratification and tumor-microenvironment analysis, while its associations require prospective and functional validation before clinical use.

• CmOGD2 and Citrus Canker Resistance: Study Insights

  2026-09-29

  The reference study identifies CmOGD2 as a key link between iron uptake, reactive oxygen species accumulation, and citron resistance to citrus canker caused by Xanthomonas citri subsp. citri. Its main innovation is the discovery of a regulatory circuit involving CmENO2, CmZAT10.1, and the pathogen effector pthA4, providing a mechanistic framework for iron- and ROS-dependent defense.

• Diminazene Aceturate: An Assay Decision Map

  2026-09-29

  Diminazene Aceturate is a versatile research reagent for connecting trypanocidal phenotypes with ACE2 activation research. This guide presents an evidence-weighted assay strategy that separates established biology from experimental inference and improves interpretation across parasite and mitochondrial studies.

• FGFR1 and Druggable Targets in Schizophrenia

  2026-09-28

  This 2025 Molecular Neurobiology study integrates drug-target Mendelian randomization, colocalization, SMR, PheWAS, drug prediction, docking, and single-cell expression analysis to prioritize schizophrenia-associated genes. FGFR1 emerged as the leading candidate, but the results represent genetically informed target prioritization rather than clinical proof of efficacy.

• ARCA EGFP mRNA (5-moUTP): Assay Guide

  2026-09-28

  Learn how to use ARCA EGFP mRNA (5-moUTP), SKU R1007, as a fluorescence-based transfection control while keeping reporter signal distinct from cell viability. This scenario-driven guide covers assay design, handling, interpretation, and practical product-selection criteria.

• 3-Methyladenine in OGD/R Autophagy Workflows

  2026-09-27

  Use 3-Methyladenine (3-MA) to test whether autophagy contributes to oxygen-glucose deprivation/reoxygenation injury, while pairing the inhibitor with mitochondrial and cell-injury readouts. This workflow draws on an SH-SY5Y study linking ERK, Drp1-dependent mitochondrial dynamics, and autophagy—and highlights why timing, vehicle controls, and dose-finding matter.

• Vitamin C Limits ROS-Linked Cochlear Cell Senescence

  2026-09-26

  A 2024 study found that vitamin C improved several senescence-associated measures in D-galactose-treated HEI-OC1 cells, alongside lower ROS-related and inflammatory signals and reduced NF-κB p65 phosphorylation. The findings support further study of ROS/NF-κB signaling in cochlear cell aging, but remain preclinical and do not establish a treatment for age-related hearing loss.

8473 records 1/565 page Next 12345 下5页 Last page